Related Experiment Video
Updated: May 9, 2026
10:52
Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
Published on: December 18, 2010
An overview of hypopituitarism's causes.
Yinbei Zhang1, Zhiyue Chen1, Lin Sun1
1Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin, China.
Frontiers in Endocrinology
|January 23, 2026
Summary
New tumor therapies and infectious diseases are expanding the causes of hypopituitarism beyond traditional factors. Understanding these evolving etiologies is crucial for accurate clinical diagnosis and future research.
Area of Science:
- Endocrinology
- Oncology
- Infectious Diseases
Background:
- Hypopituitarism etiology is expanding beyond traditional causes like pituitary tumors and trauma.
- Emerging factors include immune checkpoint inhibitors and novel infectious diseases (e.g., COVID-19).
- This necessitates a re-evaluation of diagnostic and differential diagnostic approaches.
Purpose of the Study:
- To systematically review and explore the etiology and pathogenesis of hypopituitarism.
- To cover both traditional and emerging causes of the condition.
- To provide a reference for clinical practice and future research.
Main Methods:
- Systematic literature review.
- Analysis of etiological factors and pathogenesis.
- Synthesis of information on traditional and novel causes.
Main Results:
- Identified expansion of hypopituitarism causes due to cancer immunotherapies and new infections.
- Detailed traditional causes: pituitary tumors, radiation, surgery.
- Highlighted emerging causes: immunotherapy, infections, autoimmunity.
Conclusions:
- A comprehensive understanding of evolving hypopituitarism etiologies is critical.
- Updated knowledge supports improved clinical diagnosis and differential diagnosis.
- This review provides a foundation for further research into hypopituitarism pathogenesis.
Related Concept Videos
01:17The Pituitary Gland
The pituitary is a small endocrine organ in the sphenoid bone under the hypothalamus. Primarily, the pituitary in adults has two distinct anatomical and functional regions— the anterior and posterior lobes. During human fetal development, a third pituitary gland region called the pars intermedia atrophies and disappears. However, some of its cells migrate and exist adjacent to the anterior pituitary in adults.
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...